Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
UYW8YWegRKnENXMm
Listen
